Drugs / AGT2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05206578 | Dec 2020 → Jul 2022 | hyperlipoproteinemia | Ahn-Gook Pharmaceuticals Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGT2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05206578 ↗ |